Pseudo-ADHD in a Case of First-Episode Schizophrenia: Diagnostic and Treatment Challenges

REFERENCES

• Green MF, Kern RS, Heaton RK. Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS. Schizophr Res 2004;72:41–51.
   PubMed Web of Science ®Google Scholar
• Clarke MC, Tanskanen A, Huttunen M, Increased risk of schizophrenia from additive interaction between infant motor developmental delay and obstetric complications: evidence from a population-based longitudinal study. Am J Psychiatry 2011;168:1295–302.
   PubMed Web of Science ®Google Scholar
• Turner WM, Tsuang MT. Impact of substance abuse on the course and outcome of schizophrenia. Schizophr Bull 1990;16:87–95.
   PubMed Web of Science ®Google Scholar
• Tandon R, Nasrallah HA, Keshavan MS. Schizophrenia, “just the facts” 4. Clinical features and conceptualization. Schizophr Res 2009;110:1–23.
   PubMed Web of Science ®Google Scholar
• Freudenreich O, Holt DJ, Cather C, Goff DC. The evaluation and management of patients with first-episode schizophrenia: a selective, clinical review of diagnosis, treatment, and prognosis. Harv Rev Psychiatry 2007;15:189–211.
   PubMed Web of Science ®Google Scholar
• Brent BK, Giuliano AJ, Zimmet SV, Keshavan MS, Seidman LJ. Insight into illness in patients and caregivers during early psychosis: a pilot study. Schizophr Res 2011;127:100–6.
   PubMed Web of Science ®Google Scholar
• Archie S, Akhtar-Danesh N, Norman R, Malla A, Roy P, Zipursky RB. Ethnic diversity and pathways to care for a first episode of psychosis in Ontario. Schizophr Bull 2010;36:688–701.
   PubMed Web of Science ®Google Scholar
• Perkins DO, Gu H, Boteva K, Lieberman JA. Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis. Am J Psychiatry 2005;162:1785–804.
   PubMed Web of Science ®Google Scholar
• Tsuang MT, Stone WS, Gamma F, Faraone SV. Schizotaxia: current status and future directions. Curr Psychiatry Rep 2003;5:128–34.
   PubMedGoogle Scholar
• Froehlich TE, Lanphear BP, Epstein JN, Barbaresi WJ, Katusic SK, Kahn RS. Prevalence, recognition, and treatment of attention-deficit/hyperactivity disorder in a national sample of US children. Arch Pediatr Adolesc Med 2007;161:857.
   PubMed Web of Science ®Google Scholar
• Wolraich WL, Wibbelsman CJ, Brown TE, Attention-deficit/hyperactivity disorder among adolescents: a review of the diagnosis, treatment, and clinical implications. Pediatrics 2005;115;1734–46.
   PubMed Web of Science ®Google Scholar
• Arnsten AFT. Fundamentals of attention-deficit/hyperactivity disorder: circuits and pathways. J Clin Psychiatry 2006;67(suppl 8):7–12.
   PubMed Web of Science ®Google Scholar
• Spencer TJ. ADHD and comorbidity in childhood. J Clin Psychiatry 2006;67(suppl 8):27–31.
   PubMed Web of Science ®Google Scholar
• Weiss G, Hechtman L, Perlman T, Hopkins J, Wener A. Hyperactives as young adults: a controlled prospective ten-year follow-up of 75 children. Arch Gen Psychiatry 1979;36:675.
   PubMed Web of Science ®Google Scholar
• Mannuzza S, Klein RG, Bessler A, Malloy P, LaPadula M. Adult outcome of hyperactive boys. Educational achievement, occupational rank, and psychiatric status. Arch Gen Psychiatry 1993;50:565.
   PubMed Web of Science ®Google Scholar
• Mannuzza S, Klein RG, Bessler A, Malloy P, LaPadula M. Adult psychiatric status of hyperactive boys grown up. Am J Psychiatry 1998;155:493.
   PubMed Web of Science ®Google Scholar
• Freudenreich O, Cather C, Holt D. Stimulant misuse in college for “pseudo-attention deficit disorder” during schizophrenia prodrome. Am J Psychiatry 2006;163:2019.
   PubMed Web of Science ®Google Scholar
• Tandon R, Keshavan MS, Nasrallah HA. Schizophrenia, “just the facts” what we know in 2008. 2. Epidemiology and etiology. Schizophr Res 2008;102:1–18.
   PubMed Web of Science ®Google Scholar
• Ujike H. Stimulant-induced psychosis and schizophrenia: the role of sensitization. Curr Psychiatry Rep 2002;4:177–84.
   PubMedGoogle Scholar
• Goff DC, Hill M, Barch D. The treatment of cognitive impairment in schizophrenia. Pharmacol Biochem Behav 2011;99:245–53.
   PubMed Web of Science ®Google Scholar
• Schenkel LS, Silverstin SM. Dimensions of premorbid functioning in schizophrenia: a review of neuromotor, cognitive, social, and behavioral domains. Genet Soc Gen Psychol Monogr 2004;130:241–70.
   PubMed Web of Science ®Google Scholar
• Barbaresi WJ, Katusic SK, Colligan RC, Weaver AL, Leibson CL, Jacobsen SJ. Long-term stimulant medication treatment of attention-deficit/hyperactivity disorder: results from a population-based study. J Dev Behav Pediatr 2006;27:1.
   PubMed Web of Science ®Google Scholar
• Woods SW, Breier A, Zipursky RB, Randomized trial of olanzapine versus placebo in the symptomatic acute treatment of the schizophrenic prodrome. Biol Psychiatry 2003;54:453–64.
   PubMed Web of Science ®Google Scholar
• Seidman LJ, Cassens GP, Kremen WS, Pepple JR, White RF. Neuropsychology of schizophrenia. In: White RF, ed. Clinical syndromes in adult neuropsychology: the practitioner's handbook. New York: Elsevier Science, 1992:381–449.
   Google Scholar
• Heinrichs RW, Zakzanis KK. Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology 1998;12:426–45.
   PubMed Web of Science ®Google Scholar
• Giuliano AJ, Li H, Mesholam-Gately RI, Sorenson S, Woodberry KA, Seidman LJ. Neurocognition in the psychosis risk syndrome: a quantitative and qualitative review. Curr Pharm Des 2012;18:399–415.
   PubMed Web of Science ®Google Scholar
• Mesholam-Gately RI, Giuliano AJ, Goff KP, Faraone SV, Seidman LJ. Neurocognition in first-episode schizophrenia: a meta-analytic review. Neuropsychology 2009;23:315–36.
   PubMed Web of Science ®Google Scholar
• Erlenmeyer-Kimling L, Rock D, Roberts SA, Attention, memory, and motor skills as childhood predictors of schizophrenia-related psychoses: the New York high-risk project. Am J Psychiatry 2000;157:1416–22.
   PubMed Web of Science ®Google Scholar
• Marcus J, Hans SL, Nagler S, Auerbach JG, Mirsky AF, Aubrey A. Review of the NIMH Israeli kibbutz-city study and the Jerusalem infant development study. Schizophr Bull 1987;13:425–38.
   PubMed Web of Science ®Google Scholar
• Keshavan MS, Sujata M, Mehra A, Montrose DM, Sweeney JA. Psychosis proneness and ADHD in young relatives of schizophrenia patients. Schizophr Res 2002;59:85–92.
   Web of Science ®Google Scholar
• Green MF. Cognition, drug treatment, and functional outcome in schizophrenia: a tale of two transitions. Am J Psychiatry 2007;164:992–4.
   PubMed Web of Science ®Google Scholar
• Wykes T, Huddy V, Cellard C, McGurk SR, Czobor Pl. A meta-analysis of cognitive remediation for schizophrenia: methodology and effect sizes. Am J Psychiatry 2011;168:472–85.
   PubMed Web of Science ®Google Scholar
• Hogarty GE, Flesher S, Ulrich RF, Cognitive enhancement therapy for schizophrenia: effects of a 2-year randomized trial on cognition and behavior. Arch Gen Psychiatry 2004;61:866–76.
   PubMed Web of Science ®Google Scholar
• McGurk SR, Mueser KT, Feldman K, Wolfe R, Pascaris A. Cognitive training for supported employment: 2–3 year outcomes of a randomized controlled trial. Am J Psychiatry 2007;164:437–41.
   PubMed Web of Science ®Google Scholar
• Eack SM, Hogarty GE, Greenwald DP, Hogarty SS, Keshavan MS. Effects of cognitive enhancement therapy on employment outcomes in early schizophrenia: results from a 2-year randomized trial. Res Soc Work Pract 2011;21:32–42.
   PubMed Web of Science ®Google Scholar
• Eack SM, Hogarty GE, Cho RY, Neuroprotective effects of cognitive enhancement therapy against gray matter loss in early schizophrenia: results from a 2-year randomized controlled trial. Arch Gen Psychiatry 2010;67:674–82.
   PubMed Web of Science ®Google Scholar
• Velligan DI, Bow-Thomas CC, Huntzinger C, Randomized controlled trial of the use of compensatory strategies to enhance adaptive functioning in outpatients with schizophrenia. Am J Psychiatry 2000;157:1317–23.
   PubMed Web of Science ®Google Scholar
• Friedman-Yakoobian MS, Mueser KT, Giuliano A, Goff DC, Seidman LJ. Family-directed cognitive adaptation for schizophrenia. J Clin Psychol 2009;65:854–67.
   PubMed Web of Science ®Google Scholar
• McFarlane WR, Link B, Dushay R, Psychoeducational multiple family groups: four year relapse outcome with schizophrenia. Fam Process 1995;34:127–44.
   PubMed Web of Science ®Google Scholar
• Substance Abuse & Mental Health Services Administration. National Registry of Evidence-Based Programs and Practices. Psychoeducational Multifamily Groups. 2012. http://www.nrepp.samhsa.gov/ViewIntervention.aspx?id=120
   Google Scholar
• McFarlane WR. Prevention of the first episode of psychosis. Psychiatr Clin North Am 2011;34:95–107.
   PubMed Web of Science ®Google Scholar
• Luckstead A, McFarlane WR, Downing D, Dixon L. Recent developments in family psychoeducation as an evidence-based practice. J Marital Fam Ther 2012;38:101–21.
   PubMed Web of Science ®Google Scholar
• Dixon L, Luckstead A, Medoff D, Outcomes of a randomized study of a peer-taught family-to-family education program for mental illness. Psychiatr Serv 2011;62:5915–97.
   Web of Science ®Google Scholar